Epredia Industry Spotlight

WATCH IT LIVE - Tuesday 16 February - 17:45-17:50 CET

Speakers: Barbara Cahill - Senior Global Portfolio Manager, IHC, Cytology, SA Consumables & Karla Ruegemer - Market Development Manager Tissue Processing 
"Working with the Revos tissue processor and the Lunaphore LabSat Research platform"

This sponsored scientific sessions will be streamed live to registered conference participants and afterwards will be available here for anyone to watch on demand until 15 August 2021.

Today’s challenges need modern solutions. As a global precision cancer diagnostics company, we strive to support researchers in their pursuit of diagnostic and treatment breakthroughs by providing groundbreaking technologies that meet the demands of an evolving medical research landscape. Two of Epredia’s newest solutions, the Revos™ Tissue Processor and the LabSat™ Research reagent delivery platform utilize new and innovative technologies to deliver increased workflow efficiency while enabling advanced quality results.

In this presentation, you will learn how the Revos™ Tissue Processor from Epredia helps your samples achieve the quality needed for the demands of molecular testing such as Next Generation Sequencing. Discover how Revos™ achieves rapid processing at ambient temperatures thanks to its unique canted-chamber design that allows for rotational agitation within the chamber. 

In a study to determine the efficacy of the canted chamber, researchers found that fluid dynamics created by continually breaking the reagent’s surface tension during rotational agitation allowed the tissue to process 7X faster than the traditional processors in the study without the need for added heat. In another study, we compared high heat processing with ambient temperature processing, as well as length of processing time. The results showed on average, the reduced time and heat process of Revos™ delivered better RNA and DNA yields. 

You will also experience the game-changing LabSat™ Research Platform, which provides ultra-rapid results thanks to its use of innovative microfluidic technology. Microfluidics enables efficient biomarker discovery and allows researchers to: 

• Conduct IHC and IF staining more efficiently
• Evaluate multiple biomarkers rapidly
• Ensure reliable, high quality and reproducible staining result

In a recent study estimating HER2 gene amplification in breast cancer, the microfluidic technology of the LabSat™ Research platform showed excellent linearity between antigen presence and signal intensity as compared to manual staining, highlighting the microfluidic chip’s ability to provide precise results.

Live chat

If you see a 'Let's chat' icon on the bottom right of the page, it means that a representative is online and ready to chat and answer your questions!

Click on the icon to chat with them. If you see a 'Send message' button it means nobody is online right now, but you can send an email instead.